CDK 4/6 Inhibitors in Metastatic Breast Cancer
1 विचारों
administrator
07/03/23
Hope S. Rugo, MD, discusses the use of CDK 4/6 inhibitors and their impact on the treatment paradigm for metastatic breast cancer.
और दिखाओ
फेसबुक टिप्पणियाँ
कोई टिप्पणी नहीं मिली